Organ Transplantation Market

Global Organ Transplantation Market Size

The size of the global organ transplantation market was worth USD 18.48 billion in 2024. The global market is anticipated to grow at a CAGR of 11.22% from 2025 to 2033 and be worth USD 48.12 billion by 2033 from USD 20.55 billion in 2025.

Organ transplantation is removing organs from one body and placed in another body. This process is also known as allotransplantation. This transplantation saves the life of the person who receives the Organ. The donor and receptor live in the exact location or at different locations. The donated organs can be taken from people when they die, or healthcare systems can take organs like kidneys or part of the liver from an alive person. Organs that can be transplanted include the heart, kidneys, liver, lungs, bone, tendons, ligaments, skin, and parts of the eye, intestine, and pancreas. Organ transplantation is a significant surgery, and placing an organ from one body to another is risky if the Organ has been rejected in the body of the receptor.

MARKET DRIVERS

Growing cases of organ failure are the primary cause of market growth.

Organ failure is increasing due to unhealthy lifestyle decisions, excessive alcohol and tobacco use, inactivity, and drug addiction. Increasing chronic diseases also drives the market forward. For example, a person suffering from a long-term illness may suddenly lose an organ. Therefore, the diseased Organ, such as the kidneys, liver, heart, etc., must be transplanted in these patients. For these significant reasons, the Organ transplantation market grows forward. Launching technically advanced products, advancements in 3D bioprinting, increasing government initiatives, and rising advanced transplant-related software for treatment provide opportunities for market growth. In addition, some new tissue products such as DeNovo NT Graft and Cand hondrofix Osteochondral Allegra provide benefits during treatment.

MARKET RESTRAINTS

The high cost of translation is the major restrain for market growth. Organ donation does not have any price, but organ transplantation requires a lot of money. In addition, the lack of skilled professionals, shortage of organ donors, and strict regulation rules are the challenges to market growth.

REPORT COVERAGE

SEGMENTAL ANALYSIS

By Product Type Insights

The tissue products segment led the market based on the product type, accounting for a leading share in 2024. Different types of tissue transplants include skin grafts, cartilage transplants, bone transplants, and uterine transplants. These transplants help people to regain their original working habits post to surgery. Nearly 1 million tissue grafts are distributed yearly.

By Application Type Insights

Based on the application, the kidney segment had a significant share of the global organ transplantation market in 2024. A kidney transplant is done to treat chronic kidney disease or better quality of life, lower the risk of death, and have fewer dietary restrictions. In the U.S., 24,670 kidney transplants will be performed in 2021. Increasing blood sugar and blood pressure are the primary reasons for kidney diseases.

By End-User Insights

Based on the end-user, the hospital segment occupied the most significant share of the global organ transplantation market in 2024. Orgon transplants are done in hospitals following correct procedures. These organ transplant hospitals are well equipped with advanced infrastructure for a successful rate of transplantation operations. Both organ donors and receptors are admitted to the same or different hospitals. The hospital has a list of these donors and complete details of the patient who had donated the Organ. At the same time, they also need all the receptor details to undergo transplantation surgery. As a result, the hospital segment could register domination among all the segments in the market.

REGIONAL ANALYSIS

North America led the organ transplantation market in 2024, accounting for the most significant share. In the United States, every day, 21 people die waiting for an organ, and more than 107,380 people are waiting for life-saving organ transplants. By encouraging research, education, and patient care, the American Society of Transplantation is decided to have an advanced process for transplantation to improve people's life. In 2023, according to UNOS (United Network for Organ Sharing), more than 40,000 organ transplants were performed in the U.S. Most of these recipients are between 50 and 64. The most transplanted parts in the U.S. are bones, tendons, ligaments, skin, heart valves, blood vessels, and corneas. Organ donation and transplantation numbers increased in Canada from 2025- 2033.

The Asia Pacific organ transplantation market is expected to register the fastest CAGR during the forecast period owing to the increasing prevalence of chronic diseases and increased number of organ replacement donors. China started organ donation and organ transplantation in 2023, and the number is rising. China began a website for organ donation registration in 2014. The market expands in China by raising public awareness of organ donation and improving the legal system. In Japan, Brain-dead organ transplantation has been given more priority. The National Organ and Tissue Transplant Organisation control organ donation and transplant activities in India. There were 550 transplant centers registered in India in 2023.

KEY MARKET PLAYERS

Abbvie, Inc., Arthrex, Inc., Zimmer Biomet, Medtronic, Novartis AG, Stryker, 21st Century Medicine, BiolifeSolutions, Inc., Teva Pharmaceuticals, and Veloxis Pharmaceuticals are some of the promising companies operating in the global organ transplantation market profiled in this report.

RECENT HAPPENINGS IN THE MARKET

• Lupin introduced generic Tacrolimus capsules in the American market in 2020. These capsules are indicated to prevent organ rejection in adults undergoing allogeneic kidney, liver, or heart transplants.

MARKET SEGMENTATION

This research report has segmented and sub-segmented the global organ transplantation market based on product type, application, end-user & region.

By Product Type

• Organ Preservation Products
• Transplant Diagnostics
• Immunosuppressant Drugs
• Tissue Products
• Others

By Application Type

• Organ
  • Heart
  • Kidney
  • Liver
  • Lungs
  • Pancreas
• Tissue
  • Cornea
  • Heart Valve
  • Skin Grafts
  • Vascular Graft
  • Bone Marrow
  • Bone Graft

By End-User

• Hospitals
• Blood Bank
• Stem Cell Bank
• Organ Bank
• Others

By Region

• North America
• Europe
• Asia-pacific
• Latin America
• Middle East and Africa